No Prescription |
 |
 | ||
|
DIAMOX Zolomide |
|
| ||
No Prescription » Prescription Drugs 6 » DIAMOX Zolomide Acetazolamide is used to treat glaucoma a condition in which increased pressure in the eye can lead to gradual loss of vision. Acetazolamide decreases the pressure in the eye. Acetazolamide is also used to reduce the severity and duration of symptoms (upset stomach headache shortness of breath dizziness drowsiness and fatigue) of altitude (mountain) sickness. Acetazolamide is used with other medicines to reduce edema (excess water retention) and to help control seizures in certain types of epilepsy.Acetazolamide comes as a tablet and capsule to take by mouth. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take acetazolamide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.If you are taking the extended-release (long-acting) form of acetazolamide (Diamox Sequels) do not crush or chew the capsules. Buy DIAMOX Zolomide and other Prescription Drugs 6 products online at Medstore. 564
About DIAMOX Zolomide: Product Type: Prescription Drugs 6 DIAMOX ( Zolomide Generic Acetazolamide ) DIAMOX (Zolomide Generic Acetazolamide) Zolomide Generic Acetazolamide 250mg Tabs 100 (10 x 10) Zolomide Generic Acetazolamide DIAMOX
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
